Un characterized protein C6orf136: A potential drug target and biomarker

Target Name: C6orf136

NCBI ID: G221545

C6orf136

Un characterized protein C6orf136: A potential drug target and biomarker

Abstract:
C6orf136 is a gene that encodes a protein of unknown function (Uncharacterized protein C6orf136) in humans. The protein is expressed in various tissues and cells of the body, including the brain, heart, and skeletal muscles. It has been identified as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. This article will summarize the current understanding of C6orf136 and its potential implications as a drug target and biomarker.

Introduction:
C6orf136 is a gene that encodes a protein with unknown function (Uncharacterized protein C6orf136) in humans. The protein is expressed in various tissues and cells of the body, including the brain, heart, and skeletal muscles. It has been identified as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

C6orf136 as a drug target:
C6orf136 has been identified as a potential drug target due to its unique structure and the various functions it is known to have. The protein is known to have various domains, including an N-terminal transmembrane domain, a catalytic domain, and a C-terminal cytoplasmic domain. The catalytic domain is known to have enzymes that can catalyze various chemical reactions, which may provide potential therapeutic benefits.

One of the functions of C6orf136 is its role in the regulation of cell signaling pathways. The protein has been shown to play a role in the regulation of neurotransmitter signaling pathways, which are important for various physiological processes in the brain. Additionally, C6orf136 has been shown to play a role in the regulation of cell adhesion, which is important for maintaining tissue structure and function.

C6orf136 as a biomarker:
C6orf136 has also been identified as a potential biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. This is due to its expression in various tissues and cells of the body, as well as its potential to interact with specific biomarkers.

One of the potential uses of C6orf136 as a biomarker is its ability to be used as a diagnostic tool for neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. These disorders are characterized by the progressive loss of brain cells, which can be detected using techniques such as brain imaging and histological analysis. By using C6orf136 as a biomarker, researchers may be able to diagnose these disorders earlier and begin treatment as early as possible.

Another potential use of C6orf136 as a biomarker is its ability to be used as a target for cancer therapies. Many cancer therapies work by targeting specific proteins that are over-expressed or mutated in cancer cells. By using C6orf136 as a biomarker, researchers may be able to identify cancer cells that are over-expressed or mutated for targeted therapies.

Conclusion:
In conclusion, C6orf136 is a gene that encodes a protein with unknown function (Uncharacterized protein C6orf136) in humans. The protein is expressed in various tissues and cells of the body and has been identified as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. Further research is needed to fully understand the functions of C6orf136 and its potential as a drug target and biomarker.

Protein Name: Chromosome 6 Open Reading Frame 136

The "C6orf136 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C6orf136 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets